Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]

The value and strategy for incorporating biosimilars Into clinical practice

Dr Francisco Esteva - New York University, New York, USA

The value and strategy for incorporating biosimilars Into clinical practice ( Dr Francisco Esteva - New York University, New York, USA )

Checkpoint inhibitor therapy benefits advanced bladder cancer patients

Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA

Checkpoint inhibitor therapy benefits advanced bladder cancer patients ( Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA )

Sequencing analysis with circulating DNA

Dr Oliver Zill - Guardant Health Inc, Brentwood City, USA

Sequencing analysis with circulating DNA ( Dr Oliver Zill - Guardant Health Inc, Brentwood City, USA )

Consolidative therapy extends PFS for NSCLC patients

Prof Daniel Richard Gomez - University of Texas MD Anderson Cancer Center...

Consolidative therapy extends PFS for NSCLC patients ( Prof Daniel Richard Gomez - University of Texas MD Anderson Cancer Center, Houston, USA )

Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC

Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA

Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC ( Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA )

Daratumumab slows progression in refractory multiple myeloma

Prof Palumbo - University of Turin, Turin, Italy

$Daratumumab slows progression in refractory multiple myeloma ( Prof Palumbo - University of Turin, Turin, Italy )$

Developments in haematological malignancies

Dr Stephen Nimer - University of Miami, Miami, USA

Developments in haematological malignancies ( Dr Stephen Nimer - University of Miami, Miami, USA )

MyPathway guidance of targeted therapy based on molecular profiles

Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA

MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )

Advanced RET-rearranged NSCLC

Dr Takashi Seto and Dr Kiyotaka Yoh

Advanced RET-rearranged NSCLC ( Dr Takashi Seto and Dr Kiyotaka Yoh )

Update on olaparib in ovarian cancer

Prof Jonathan Ledermann - University College Hospital Medical School, London, UK

Update on olaparib in ovarian cancer ( Prof Jonathan Ledermann - University College Hospital Medical School, London, UK )

Impact of precision medicine in refractory malignancies

Prof Maria Schwaederle - University of California, San Diego, USA

$Impact of precision medicine in refractory malignancies ( Prof Maria Schwaederle - University of California, San Diego, USA )$

ASCO 2016: Plenary Session Review

Dr Julie Vose - President of ASCO

ASCO 2016: Plenary Session Review ( Dr Julie Vose - President of ASCO )

More from ecancer